Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T13:25:54.119Z.
Calculation as of: 2026-10-06T13:25:54.119Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 412370d08cb3fb7a3c2e4d636897a8ea9259835d42853a062d33098765049a4f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2016-03-31.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$368.91M
EV/EBIT Ratio
N/A
TTM Avg
55.83x
3Y Avg
55.83x
5Y Avg
55.83x
Market Cap
$366.39M
EV/EBIT Ratio
N/A
TTM Avg
45.54x
3Y Avg
33.14x
5Y Avg
24.49x
Market Cap
$348.59M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $373.40M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $368.91M | N/A | 55.83x | 55.83x | 55.83x |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $366.39M | N/A | 45.54x | 33.14x | 24.49x |
| Agenus Inc. (AGEN)vs › | $363.54M | 10.65x | 35.72x | 35.72x | 18.31x |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $384.23M | N/A | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $348.85M | 6.46x | 5.53x | 9.02x | 8.48x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $348.59M | N/A | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $345.48M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2016-03-31 | 1187.53x |
| 2016-03-30 | 1184.54x |
| 2016-03-29 | 1158.24x |
| 2016-03-28 | 1173.18x |
| 2016-03-24 | 1169.00x |
| 2016-03-23 | 1145.69x |
| 2016-03-22 | 1228.17x |
| 2016-03-21 | 1228.17x |
| 2016-03-18 | 1243.71x |
| 2016-03-17 | 1241.32x |
| 2016-03-16 | 1179.76x |
| 2016-03-15 | 1190.52x |
| 2016-03-14 | 1229.37x |
| 2016-03-11 | 1263.44x |
| 2016-03-10 | 1279.57x |
| 2016-03-09 | 1298.10x |
| 2016-03-08 | 1285.55x |
| 2016-03-07 | 1301.69x |
| 2016-03-04 | 1316.03x |
| 2016-03-03 | 1298.10x |
| 2016-03-02 | 1323.21x |
| 2016-03-01 | 1328.59x |
| 2016-02-29 | 1296.91x |
| 2016-02-26 | 1277.78x |
| 2016-02-25 | 1266.43x |
| 2016-02-24 | 1277.78x |
| 2016-02-23 | 1345.32x |
| 2016-02-22 | 1246.70x |
| 2016-02-19 | 1197.09x |
| 2016-02-18 | 1194.10x |
| 2016-02-17 | 1204.26x |
| 2016-02-16 | 1170.20x |
| 2016-02-12 | 1158.84x |
| 2016-02-11 | 1104.45x |
| 2016-02-10 | 1111.62x |
| 2016-02-09 | 1126.56x |
| 2016-02-08 | 1088.31x |
| 2016-02-05 | 1125.96x |
| 2016-02-04 | 1148.68x |
| 2016-02-03 | 1140.31x |
| 2016-02-02 | 1110.42x |
| 2016-02-01 | 1153.46x |
| 2016-01-29 | 1137.32x |
| 2016-01-28 | 1126.56x |
| 2016-01-27 | 1134.93x |
| 2016-01-26 | 1128.95x |
| 2016-01-25 | 1125.96x |
| 2016-01-22 | 1140.31x |
| 2016-01-21 | 1122.38x |
| 2016-01-20 | 1092.49x |
| 2016-01-19 | 1099.07x |
| 2016-01-15 | 1107.44x |
| 2016-01-14 | 1152.26x |
| 2016-01-13 | 1159.44x |
| 2016-01-12 | 1188.72x |
| 2016-01-11 | 1192.91x |
| 2016-01-08 | 1171.99x |
| 2016-01-07 | 1088.91x |
| 2016-01-06 | 1191.11x |
| 2016-01-05 | 1237.14x |
| 2016-01-04 | 1241.92x |
| 2015-12-31 | 1327.58x |
| 2015-12-30 | 1313.37x |
| 2015-12-29 | 1310.28x |
| 2015-12-28 | 1296.08x |
| 2015-12-24 | 1296.08x |
| 2015-12-23 | 1275.69x |
| 2015-12-22 | 1243.57x |
| 2015-12-21 | 1257.78x |
| 2015-12-18 | 1241.72x |
| 2015-12-17 | 1234.31x |
| 2015-12-16 | 1296.08x |
| 2015-12-15 | 1258.40x |
| 2015-12-14 | 1240.48x |
| 2015-12-11 | 1229.98x |
| 2015-12-10 | 1270.13x |
| 2015-12-09 | 1271.37x |
| 2015-12-08 | 1273.84x |
| 2015-12-07 | 1337.46x |
| 2015-12-04 | 1312.14x |
| 2015-12-03 | 1273.22x |
| 2015-12-02 | 1282.49x |
| 2015-12-01 | 1276.93x |
| 2015-11-30 | 1296.08x |
| 2015-11-27 | 1267.04x |
| 2015-11-25 | 1134.85x |
| 2015-11-24 | 1124.97x |
| 2015-11-23 | 1100.88x |
| 2015-11-20 | 1104.59x |
| 2015-11-19 | 1106.44x |
| 2015-11-18 | 1169.45x |
| 2015-11-17 | 1221.95x |
| 2015-11-16 | 1089.76x |
| 2015-11-13 | 1027.99x |
| 2015-11-12 | 1015.02x |
| 2015-11-11 | 1137.33x |
| 2015-11-10 | 1228.13x |
| 2015-11-09 | 1257.16x |
| 2015-11-06 | 1228.13x |
| 2015-11-05 | 1478.92x |
| 2015-11-04 | 1592.58x |
| 2015-11-03 | 1481.39x |
| 2015-11-02 | 1378.85x |
| 2015-10-30 | 1276.31x |
| 2015-10-29 | 1173.77x |
| 2015-10-28 | 1203.42x |
| 2015-10-27 | 1192.92x |
| 2015-10-26 | 1096.56x |
| 2015-10-23 | 1048.99x |
| 2015-10-22 | 1146.59x |
| 2015-10-21 | 1018.11x |
| 2015-10-20 | 957.57x |
| 2015-10-19 | 1034.79x |
| 2015-10-16 | 966.84x |
| 2015-10-15 | 955.10x |
| 2015-10-14 | 899.51x |
| 2015-10-13 | 838.97x |
| 2015-10-09 | 826.00x |
| 2015-10-07 | 805.00x |
| 2015-10-06 | 840.82x |
| 2015-10-05 | 761.76x |
| 2015-10-02 | 751.87x |
| 2015-10-01 | 756.20x |
